Design Therapeutics (DSGN) Net Income towards Common Stockholders (2020)
Historic Net Income towards Common Stockholders for Design Therapeutics (DSGN) over the last 1 years, with Q4 2020 value amounting to -$3.9 million.
- Design Therapeutics' Net Income towards Common Stockholders changed N/A to -$3.9 million in Q4 2020 from the same period last year, while for Sep 2021 it was -$3.9 million, marking a year-over-year change of. This contributed to the annual value of -$8.3 million for FY2020, which is N/A changed from last year.
- As of Q4 2020, Design Therapeutics' Net Income towards Common Stockholders stood at -$3.9 million.
- In the past 5 years, Design Therapeutics' Net Income towards Common Stockholders registered a high of -$623000.0 during Q1 2020, and its lowest value of -$3.9 million during Q4 2020.